Description

Patomostat Mesilate is a high-purity pharmaceutical intermediate and active ingredient of significant importance in modern therapeutic development. Its primary value lies in its role as a key building block for the synthesis of advanced protease inhibitors and other specialized active pharmaceutical ingredients (APIs). This compound is essential for research institutions, pharmaceutical manufacturers, and fine chemical suppliers engaged in the development and production of novel drug candidates targeting specific enzymatic pathways.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of complex protease inhibitor drugs.
• Active Pharmaceutical Ingredient (API) Development: Used in research and development for creating new therapeutic entities, particularly in oncology and virology.
• Biochemical Research: Employed as a reference standard or tool compound in enzymatic studies and mechanism-of-action investigations.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for cGMP production of clinical trial materials and commercial APIs.
• Process Chemistry: Utilized in route scouting, optimization, and scale-up activities within pharmaceutical R&D departments.

Basic Information

Product Name	Patomostat Mesilate
CAS No.	114568-32-0
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Patomostat Methanesulfonate; Patomostat Mesylate; 114568-32-0; Patomostat (mesylate salt); Patomostat monomethanesulfonate; Patomostat MS; Patomostat Methanesulphonate
EINECS	Contact for details

Quality Control

Our Patomostat Mesilate is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. The product undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to confirm identity and potency. A comprehensive Certificate of Analysis (COA) is provided with each batch, detailing purity, related substances, residual solvents, and other critical parameters. We support development and commercial projects requiring compliance with cGMP, ICH Q7, and other relevant pharmaceutical guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC/IR)	Conforms to reference standard
Assay (HPLC)	≥98.0%
Related Substances (HPLC)	Total impurities ≤2.0%
Water Content (KF)	≤1.0%
Residual Solvents (GC)	Complies with ICH limits

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.